An interdisciplinary journal for the dissemination of clinical and basic science research relating to acute care medicine and cardiopulmonary resuscitation Clinical and experimental research, reviews and case histories, and description of methods used in clinical and experimental resuscitation are encouraged. Recognised by the European Resuscitation Council as its official Journal
Guide for Authors
Guide for Authors Resuscitation is a monthly interdisciplinary medical journal and is the official journal of the
European Resuscitation Council. The papers published deal with the aetiology, pathophysiology and prevention of cardiac arrest, resuscitation
training, clinical resuscitation, and experimental resuscitation research. Case reports will be published only if they are of exceptional
interest and originality. Review articles and Letters to the Editor, particularly relating to articles previously published in Resuscitation,
are welcome.
Editorial policy
The originality of content of papers submitted and the quality of the work on which they
are based is the prime consideration of the editors. The paper should deal with original material, neither previously published nor being
considered for publication elsewhere, except in special circumstances agreed with the Editor-in-Chief. Most papers are assigned to an
editor and sent for peer review; papers may be returned to authors as accepted, for reconsideration after revision, or rejection. The
reviewers name may or may not be revealed to the author(s), depending on the reviewer's preference. The decision of the Editor-in-Chief
regarding acceptance or rejection is final. Some papers that clearly are not within the scope of the journal or are far below the standard
for publication in Resuscitation will be rejected by the Editor-in-Chief without obtaining peer review. Resuscitation operates a word
limit for all articles as detailed in the table below. Manuscripts will be returned to the author if the word count is exceeded.
WORD LIMIT (excluding abstract and references)
Original Paper* 3000
Short Paper* 1500
Review* 4000
Editorial
1200
Case report 1000
Letter to Editor 500
Images 300
TABLES/ILLUSTRATION LIMIT
Original Paper* 6
Short
Paper 3
Review* 8
Editorial 1
Case report 2
Letter to Editor 1
Images 3
REFERENCE LIMIT
Original
Paper* 40
Short Paper 20
Review* 75
Editorial 20
Case report 15
Letter to Editor 5
Images 2
*option for supplementary
on line materials
Guide for Authors
These guidelines generally follow the 'Uniform Requirements for Manuscripts Submitted
to Biomedical Journals' The complete document appears at http://www.icmje.org
Submission
of papers
Authors must submit their original manuscript and figures online via http://ees.elsevier.com/resus which
is the Elsevier web-based submission and peer-review system. You will find full instructions located on this site - a Guide for Authors
and a Guide for Online Submission. Please follow these guidelines to prepare and upload your article.
Once the manuscript has been
uploaded, our system automatically generates an electronic PDF proof, which is then used for reviewing. All correspondence, including
notification of the Editor's decision and requests for revisions, will be managed via this system. Authors may also track the progress
of their paper using this system to final decision.
If you have any problems submitting your paper through this system, please contact
the Editorial Office on: e-mail: resus@elsevier.com; tel: +44 (0)1865 843620; fax: +44 (0)1865 843992.
Upon acceptance
of an article, authors will be asked to sign a 'Journal Publishing Agreement' (for more information on this and copyright see http://www.elsevier.com/copyright).
Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail will be sent to the corresponding
author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this
agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation
within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other
derivative works, including compilations and translations (please consult http://www.elsevier.com/permissions).
If
excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit
the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult http://www.elsevier.com/permissions.
Your manuscript should be submitted together with a covering letter which should be signed by the corresponding author on behalf of
all authors and should include:
* A statement that all authors have made substantial contributions to all of the following: (1) the
conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising
it critically for important intellectual content, (3) final approval of the version to be submitted. All contributors who do not meet
the criteria for authorship as defined above should be listed in an acknowledgements section. Examples of those who might be acknowledged
include a person who provided purely technical help, writing assistance, or is the chair of the department who provided only general
support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance.
*
A statement that the manuscript, including related data, figures and tables, has not been published previously and that the manuscript
is not under consideration elsewhere.
* The names and contact addresses (including e-mail) of two potential reviewers that have not
been involved in the design, performance and discussion of the data and are not a co-worker. These may or may not be used at the Editor's
discretion. You may also mention persons who you would prefer not to review your paper.
Conflict of interest
At the end
of the text, under a subheading 'Conflict of interest statement' all authors must disclose any financial and personal relationships with
other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include
employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other
funding. If an author has no conflict of interest, state this explicitly.
Role of the funding source
All sources of funding
must be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the study
design, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript
for publication. If the study sponsors had no such involvement, the authors should so state. Please see http://www.elsevier.com/funding
Randomised controlled trials Resuscitation has adopted the proposal from the International Committee of Medical
Journal Editors (ICMJE) which require, as a condition of consideration for publication of clinical trials, registration in a public trials
registry. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included
at the end of the abstract of the article. For this purpose, a clinical trial is defined as any research project that assigns human subjects
prospectively to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health
outcome. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g. phase I trials) would be exempt.
Further information can be found at www.icmje.org.
Ethics and Patient Consent
Work on human beings that
is submitted to Resuscitation must comply with the principles laid down in the Declaration of Helsinki; Recommendations guiding
physicians in biomedical research involving human subjects. Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964,
amended by the 29th World Medical Assembly, Tokyo, Japan, October 1975, the 35th World Medical Assembly, Venice, Italy, October 1983,
and the 41st World Medical Assembly, Hong Kong, September 1989. The manuscript must contain a statement that the work has been approved
by the appropriate ethical committees related to the institution(s) in which it was performed and that, where appropriate, subjects gave
informed consent to the work. Patients have a right to privacy that should not be infringed without informed consent. Identifying information,
including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees
unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for
publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors
should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print
after publication.
Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however,
and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate
protection of anonymity.
Studies involving experiments with animals must state that their care was in accordance with institution
guidelines.
Images for Resuscitation
Readers are invited to submit original high quality images. Images may show clinical
signs, the results of investigations, pieces of equipment, be of historical interest or indeed anything that they feel will be of interest
to the resuscitation community. Describe and explain all labelled features in the image. Limit the legend to a maximum of 300 words and
two references. Submit images to http://ees.elsevier.com/resus. For further information on the preparation of electronic
artwork, please visit http://www.elsevier.com/artworkinstructions. Images will be considered for publication provided that
they have not been submitted or published elsewhere. Colour reproduction, when appropriate, will be available at no charge otherwise
the image will be published in black and white.
Structure of papers
Papers must comply with the word count and figure,
table and reference limit listed above.
All papers must include a separate title page documenting: authors' full names, academic
and professional affiliations and complete addresses; the name and address of the corresponding author; the word count of the paper and
the abstract (if applicable).
Original papers, reviews and short papers must include an abstract of no longer than 250 words. This
should be a structured abstract listing the aim of the study (or review), the methods (or 'data sources' for a review), the results and
the conclusion. Case reports must include a brief abstract of no more than 100 words that summarises the key learning points.
Papers
must be written concisely and conform to the style of Resuscitation. They should be clearly divided into sections: Introduction;
Methods; Results; Discussion; Conclusions; Conflicts of Interest; Acknowledgments; References; Legends to figures. For review papers,
use appropriate sub-headings instead of methods, results and discussion.
Language
All papers submitted to the Editor-in-Chief
must use 'English' spelling e.g. haemodynamic, ischaemia, aetiology, oesophagus etc. Use generic names for all drugs. The term 'adrenaline'
is preferred to 'epinephrine': for the first use only, 'adrenaline' should be followed by 'epinephrine' in brackets (parentheses). Similar
arrangements apply to noradrenaline and norepinephrine.
Resuscitation has an international readership: keep abbreviations
to a minimum and confine as much as possible to those in regular use. Too many abbreviations make reading difficult. Abbreviations of
units must conform to the International System of Units (SI), for example, kg, g, mg, cm, mm, ml, mg kg-1. Plurals have the same abbreviations
as used for the singular. If non-regular abbreviations are used supply a list of these with their definitions as a footnote to page 1.
Do not use abbreviations of this type in the Abstract.
Insert citations in superscript (after punctuation) and list the references
on a separate sheet in numerical sequence in the order in which they are first mentioned in the text. References cited only in tables
or figure legends are numbered in accordance with the sequences established by the first identification in the text of the particular
figure or table. List all authors when there are six or less; when there are seven or more, list the first three, then 'et al'. Abbreviate
the titles of journals according to the style used in Index Medicus. The list of journals can be found at http://www.nlm.nih.gov/tsd/serials/terms_cond.html
The following are sample references: Articles in Journals
1. Ross P, Nolan J, Hill E, Dawson J, Whimster F. The use of
AEDs by police officers in the City of London. Resuscitation 2001;50:141-6.
2. Bernard SA, Gray TW, Buist MD, et al. Treatment of
comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;346:557-63. Books
3.
Armitage P. Statistical methods in medical research. London, Blackwell Scientific Publications, 1971. Chapters
4. Phillips
SJ, Whisnant JP Hypertension and stroke. In Laragh JH, Brenner BM, editors. Hypertension: Pathophysiology, diagnosis, and management.
2nd ed. New York, Raven Press, 1995: 465-78. References to electronic publications
Working Group of the Resuscitation
Council (UK). Emergency treatment of anaphylactic reactions. Guidelines for healthcare providers. London, Resuscitation Council (UK),
2008. (Accessed 11 August 2008, at http://www.resus.org.uk/pages/reaction.pdf)
Numbered references to personal communications,
unpublished data or manuscripts either 'in preparation' or 'submitted for publication' are unacceptable. If essential, include this material
at the appropriate place in the text. Illustrations must be in a form and condition suitable for reproduction. The illustration should
bear the manuscript titles and be numbered in Arabic numerals according to the sequence of their appearance in the text, where they should
be referred to as Fig. 1, Fig. 2, etc. Line-drawings should be drawn at least twice the size of their final intended appearance. Lettering
should be clear and of adequate size to be legible after reduction. The extent of reduction will be determined by the publisher, but
in general the same reduction will be applied to all figures in the same paper. Reproduction in colour is subject to approval by the
Editor-in-Chief and Publisher. The extra costs of print colour reproduction will be charged to the author(s) although colour reproduction
online is free of charge. Each illustration must have a legend that is typed with double spacing on a separate page and beginning with
the number of the illustration they refer to.
Tables of numerical data are typed (also with double-spacing) on a separate page, numbered
in sequence in Arabic numerals (Table 1, 2, etc.) and provided with a heading, a legend, and referred to the text as Table 1, Table 2,
etc.
Authors in Japan please note: upon request, Elsevier Japan will provide authors with a list of people who can check and improve
the English of their paper (before submission). Please contact our Tokyo office: Elsevier Japan, 9-15, Higashi-Azabu 1-chome, Minato-ku,
Tokyo 106-0044; Japan; Tel. (+81) 3-5561-5032; Fax: (+81)3-5561-5045; E-mail: info@elsevier.co.jp.
Elsevier has negotiated
with several language editing companies to provide language editing services to our authors at competitive rates. Asia Science Editing,
Diacritech Language Editing Services, Edanz Editing, International Science Editing, ScienceDocs Editing Services and SPI Publisher Services
provide language and copy editing services globally to authors who would like assistance either before they submit an article for peer
review or before it is accepted for publication. http://www.elsevier.com/wps/find/authorsview.authors/languagepolishing
Statistical Methods
* Use nonparametric methods to compare groups when the distribution of the dependent variable is not
normal.
* Use measures of uncertainty (e.g. confidence intervals) consistently.
* Report two-sided P values except when one-sided
tests are required by study design (e.g., non-inferiority trials). Report P values larger than 0.01 to two decimal places, those between
0.01 and 0.001 to three decimal places; report P values smaller than 0.001 as P<0.001.
* All randomised controlled trials submitted
for publication in Resuscitation should include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart. Please refer
to the CONSORT statement website at http://www.consort-statement.org for more information.
Funding body agreements
and policies Elsevier has established agreements and developed policies to enable authors who publish in Elsevier journals to comply
with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements
and policies please visit http://www.elsevier.com/fundingbodies.
Author Enquiries
The facility to track accepted articles and set up e-mail alerts to inform you when an article's status
changes can be found at: http://authors.elsevier.com/TrackPaper.html. There is also information on artwork guidelines,
copyright information, and answers to frequently asked questions.
Proofs
One set of page proofs in PDF format will be
sent by e-mail to the corresponding author. Elsevier now sends PDF proofs which can be annotated; for this you will need to download
Adobe Reader version 8 available free from http://www.adobe.com/products/acrobat/readstep2.html. Instructions on how to
annotate PDF files will accompany the proofs. The exact system requirements are given at the Adobe site: http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return
to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections
and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail,
or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures.
Once accepted for publication, significant changes to the article will be considered at this stage only with permission from the Editor-in-Chief.
We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure that all of
your corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections
cannot be guaranteed. Proof reading is solely your responsibility. Elsevier may proceed with the publication of your article if no response
is received.
All questions relating to proofs should be directed to: Elsevier Ireland Ltd., Editorial Department, Brookvale Plaza,
East Park, Shannon, Co. Clare, Ireland. E mail g.gallagher@elsevier.com.
Reprints
The corresponding author,
at no cost, will be provided with a PDF file of the article via e-mail. The PDF file is a watermarked version of the published article
and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use. Paper offprints can
be ordered by the authors. An order form with prices will be sent to the corresponding author.Keywords: Acid-base; Acidaemia;
Acidosis; Action potential; Active compression-decompression; Acute respiratory distress syndrome; Adenosine; Adenosine triphosphate;
Adrenal gland; Adrenaline; Adrenergic agonist/antagonist; Adrenoreceptor; Adult; Advanced directive; Advanced Life Support (ALS); Age;
Aged; Agonist; Air embolism; Airway; Airway management; Airway obstruction; Albumin; Alcohol; Algorithm; Alkalosis; Ambulance; American
Heart Association; Amiodarone; Anaesthesia; Anaphylaxis; Anatomy; Angiotensin; Anoxia; Antagonist; Antiarrhythmic drugs/therapy; Anticoagulant;
Anticonvulsant; Aorta; Aortic pressure; Arrhythmia; Asphyxia; Aspiration; Asthma; Asystole; Atherosclerosis; Atrioventricular node; Atropine;
Automated external defibrillator (AED); Avalanche; Bag-valve-mask; Barbiturate; Barotrauma; Basic Airway Management; Basic Life Support
(BLS); Beta-adrenergic agonist; Beta-adrenergic receptor; Bicarbonate; Blood; Blood gases; Blood pressure; Bradyarrhythmias; Brain injury;
Brain ischaemia; Breathing; Bretylium; Buffer (therapy); Burn injury; Bystander CPR; Calcium; Calcium channel blocker; Cannulation; Capnography;
Carbon dioxide; Carbon monoxide; Cardiac arrest; Cardiac massage; Cardiac output; Cardiac pacing, artificial; Cardiac tamponade; Cardiogenic
shock; Cardiomyopathy; Cardiopulmonary resuscitation (CPR); Catecholamines; Catheter; Cerebral blood flow; Cerebral perfusion pressure;
Chemicals; Chest compression; Child; Chronic obstructive pulmonary disease; Circulation; Clinical trials; Closed chest cardiac massage;
Colloid; Combitube; Coronary circulation; Coronary perfusion pressure; Cost; Cricothyroidotomy; Crystalloid; Defibrillation; Dialysis;
Digoxin; Diseases; Diuretic; Do not resuscitate orders; Dopamine; Drowning; Drug therapy; Echocardiography; Education; Electrocardiography;
Electrocution; Electroencephalography; Electrolytes; Embolism; Emergency medical services; Emergency medical technician; Emergency treatment;
End-tidal carbon dioxide; Endothelial injury; Endothelin-1; Epinephrine; Ethics; Europe; European Resuscitation Council; External chest
compression (ECC); Extracorporeal membrane oxygenation; Fast Fourier transformation; Fluid therapy; Free radical; Gas exchange; Gastric
regurgitation; Gastrointestinal system; Glasgow Coma Scale; Glucose; Glutamate; Guidelines; Guillain Barre Syndrome; Haemodynamics; Haemoglobin;
Haemorrhage; Heart arrest;
Heart block; Heart disease; Heart failure; Heparin; High-dose epinephrine; Human experimentation: clinical
trials; Human immunodeficiency virus (HIV); Hyperbaric oxygen; Hypercarbia; Hyperglycaemia; Hypertension; Hypocalcaemia; Hypoglycaemia;
Hypokalaemia; Hypotension; Hypothermia; Hypovolaemia; Hypoxia; Impedance; Implantable cardiovertor defibrillator (ICD); Infant; Infection;
Inflammatory response; Informed consent; Intensive care; Interposed abdominal compression - CPR; Intoxication; Intracranial pressure;
Intraosseous; Intraosseous infusion; Intravenous; Intubation; Ischaemia; Jugular vein; Lactate; Lactic acidosis; Laryngeal mask airway;
Laryngoscopy; Left ventricle; Lidocaine; Lightning injury; Lidocaine; Liver; Long Q T syndrome; Lung; Magnesium; Manikin; Manual defibrillator;
Maternal cardiac arrest; Medical Emergency Team; Medical futility; Megacode training; Membrane; Metabolic acidosis; Metabolism; Metanalysis;
Methaemoglobin; Methodology; Microcirculation; Mitochondria; Monitoring; Mouth-to-mouth; Mouth-to-mask resuscitation; Mouth-to-mouth
resuscitation; Multiple organ failure; Myocardial blood flow; Myocardial infarction; Myocardium; Naloxone; Near drowning; Neonatal resuscitation;
Neurological dysfunction; Neurones; Neurotransmitter; Nitric oxide; Nitroglycerin; NMDA receptor;
Noradrenaline; Obesity; Open chest
cardiac compression (OCCC); Orotracheal intubation; Out-of-hospital CPR; Outcome; Overdose; Oximetry; Oxygen; Pacemaker; Pacing; Paediatric
resuscitation; Pain; Paramedic; Pericardial tamponade; Pericardiocentesis; Peripheral vascular resistance; Pharmacodynamics; Phenylephrine;
Phenytoin; Phosphate; Phosphodiesterase inhibitor; Pituitary gland; Pneumothorax; Poisoning; Polymorphic ventricular tachycardia; Positive
end-expiratory pressure (PEEP); Post-resuscitation period; Potassium; Pregnancy; Pressure; Prevention; Prophylaxis; Pulmonary artery
catheter; Pulmonary aspiration; Pulmonary embolism; Pulmonary hypertension; Pulmonary oedema; Pulseless electrical activity (PEA); QRS
complex; QT interval; Quality of life; Re-entry; Renin; Reperfusion; Respiration; Respiration, artificial; Respiratory arrest; Respiratory
system; Resuscitation; Return of spontaneous circulation; Routes of drug administration; Safety; Schools; Septic shock; Shock; Simultaneous
compression-ventilation - CPR; Sinoatrial node; Socio-economic status; Sodium; Sodium bicarbonate; Spinal cord; Spinal cord injury; Status
asthmaticus; Status epilepticus; Stroke; Stroke volume; Stunning, myocardial; Sudden cardiac death; Sudden infant death syndrome; Superoxide
dismutase; Synapses; Systemic vascular resistance; Tachyarrhythmias; Temperature; Tension pneumothorax; Thermal injury, heat exhaustion;
Thoracocentesis; Thoracotomy; Thrombolysis; Thump, precordial; Tidal volume; Torsades de Pointes; Toxicity; Trachea; Tracheal intubation;
Tracheostomy; Training; Transoesophageal echocardiography (TOE); Transplant, heart; Transport; Transthoracic impedance; Trauma; Triage;
Utstein template; Vasopressin; Vasopressor therapy; Ventilation; Ventricular arrhythmia; Ventricular assist device; Ventricular fibrillation;
Ventricular tachycardia (VT); Witnessed cardiac arrest; Wolff-Parkinson-White syndrome.
Papers should be concisely written and conform
to the style of Resuscitation. Generally they should be clearly divided into numbered sections, 1. Introduction, 2. Methods,
3. Results, 4. Discussion, 5. Conclusions, 6. Conflict of Interest, 7. Acknowledgments, 8. References, 9. Legends to figures etc.
Language
Resuscitation is an international journal and it is the aim of the Editors to produce papers in clear and concise
language. Brief sentences make for easy reading. Do not use a long word or phrase if there is an equivalent short one ('now' is better
than 'at this moment in time' and 'use' is better than 'utilise'). Avoid the use of 'split infinitives' such as 'to better know' - replace
with 'to know better'.
'American' spelling is acceptable for papers sent to the American Editor e.g. hemodynamic, ischemic, etiology,
esophagus, but for all other papers submitted to the Editor in Chief use 'English' spelling e.g. haemodynamic, ischaemia, aetiology,
oesophagus.
Use generic names for all drugs. There is a difference in terminology with certain drugs between North America and most
of the rest of the world e.g. adrenaline and epinephrine. In Papers submitted to the American Editor use the term 'epinephrine' throughout
with 'adrenaline' in brackets after the first mention of the drug only. For all other papers use the term 'adrenaline' throughout with
'epinephrine' in brackets after the first mention of the drug only. Similar arrangements apply to noradrenaline and norepinephrine.
Certain terms are preferred e.g. 'external chest compressions' to 'external cardiac massage'. Avoid regional or local terms. Thus 'code'
is replaced by 'emergency' and 'Trust' is replaced by 'Group of Hospitals'. Resuscitation has an international readership. Keep
abbreviations to a minimum and confine as much as possible to those in regular use. Too many abbreviations make reading difficult. Abbreviations
of units must conform to the International System of Units (SI), for example, kg, g, mg, cm, mm, ml, mg kg-1. Plurals have
the same abbreviations as used for the singular. If non-regular abbreviations are used supply a list of these with their definitions
as a footnote to page 1. Do not use abbreviations of this type in the Abstract.
Statistical treatment of results will be expected
wherever this is appropriate.
Insert citations in superscript (after punctuation) and list the references on a separate sheet in numerical
sequence in the order in which they are first mentioned in the text. References cited only in tables or figure legends are numbered in
accordance with the sequences established by the first identification in the text of the particular figure or table. List all authors
when there are six or less; when there are seven or more, list the first three, then 'et al'. Abbreviate the titles of journals according
to the style used in Index Medicus. The list of journals can be found at http://www.nlm.nih.gov/tsd/serials/terms_cond.html
The following are sample references:
Articles in Journals
1. Ross P, Nolan J, Hill E, Dawson J, Whimster F. The use of AEDs
by police officers in the City of London. Resuscitation 2001;50:141-6.
2. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose
survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;346:557-63.
Books
3. Armitage P. Statistical
methods in medical research. London: Blackwell Scientific Publications, 1971. Chapters
4. Phillips SJ, Whisnant JP Hypertension and
stroke. In Laragh JH, Brenner BM, editors. Hypertension: Pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press; 1995.
P465p.465-78.
Numbered references to personal communications, unpublished data or manuscripts either 'in preparation' or 'submitted
for publication' are unacceptable. If essential, include this material at the appropriate place in the text. Illustrations must be in
a form and condition suitable for reproduction. The illustration should bear the manuscript titles and be numbered in Arabic numerals
according to the sequence of their appearance in the text, where they should be referred to as Fig. 1, Fig. 2, etc. Line-drawings should
be drawn at least twice the size of their final intended appearance. Lettering should be clear and of adequate size to be legible after
reduction. The extent of reduction will be determined by the publisher, but in general the same reduction will be applied to all figures
in the same paper. Reproduction in colour is subject to approval by the Editor and Publisher. The extra costs of colour reproduction
will be charged to the author(s). Each illustration must have a legend that is typed with double spacing on a separate page and beginning
with the number of the illustration they refer to.
Tables of numerical data are typed (also with double-spacing) on a separate page,
numbered in sequence in Arabic numerals (Table 1, 2, etc.) and provided with a heading, a legend, and referred to the text as Table 1,
Table 2, etc.
Authors in Japan please note: Upon request, Elsevier Japan will provide authors with a list of people who can check
and improve the English of their paper (before submission). Please contact our Tokyo office: Elsevier Japan, 9-15, Higashi-Azabu 1-chome,
Minato-ku, Tokyo 106-0044; Japan; Tel. (+81) 3-5561-5032; Fax: (+81)3-5561-5045; E-mail: info@elsevier.co.jp. English
language help service: Upon request, Elsevier will direct authors to an agent who can check and improve the English of their paper (before
submission). Please contact authorsupport@elsevier.com for further information.
Funding body agreements and policies
Elsevier has established agreements and developed policies to enable authors who publish in Elsevier journals to comply with potential
manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies
please visit http://www.elsevier.com/fundingbodies.
Author Enquiries
The facility to track accepted articles and set up e-mail alerts to inform you when an article's status changes
can be found at: http://authors.elsevier.com/TrackPaper.html. There is also information on artwork guidelines, copyright
information, and answers to frequently asked questions.
Proofs
One set of page proofs in PDF format will be sent by e-mail
to the corresponding author. Elsevier now sends PDF proofs which can be annotated; for this you will need to download Adobe Reader version
8 available free from http://www.adobe.com/products/acrobat/readstep2.html. Instructions on how to annotate PDF files will
accompany the proofs. The exact system requirements are given at the Adobe site: http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return
to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections
and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail,
or by post.
Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures.
Once accepted for publication, significant changes to the article will be considered at this stage only with permission from the Editor.
We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure that all of
your corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections
cannot be guaranteed. Proof reading is solely your responsibility. Elsevier may proceed with the publication of your article if no response
is received.
All questions relating to proofs should be directed to: Elsevier Ireland Ltd., Editorial Department, Brookvale Plaza,
East Park, Shannon, Co. Clare, Ireland. E mail g.gallagher@elsevier.com.
Reprints
The corresponding author,
at no cost, will be provided with a PDF file of the article via e-mail or, alternatively, 25 free paper offprints. The PDF file is a
watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms
and conditions of use. Paper offprints can be ordered by the authors. An order form with prices will be sent to the corresponding author.
